Has the time for first-line treatment with second generation tyrosine kinase inhibitors in patients with chronic myelogenous leukemia already come? Systematic review and meta-analy...

Por Gurion, Ronit, Gafter-Gvili, Anat, Vidal, Liat, Leader, Avi, Ram, Ron, Shacham-Abulafia, Adi, Paul, Mical, Ben-Bassat, Isaac, Shpilberg, Ofer, Raanani, Pia
Publicado em 2013